What is Lifesci Capital’s Estimate for AVDL Q2 Earnings?
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Equities research analysts at Lifesci Capital issued their Q2 2025 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti forecasts that the company will post earnings of $0.02 per share for the quarter. The consensus […]
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Equities research analysts at Lifesci Capital issued their Q2 2025 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a report issued on Monday, March 3rd. Lifesci Capital analyst M. Belghiti forecasts that the company will post earnings of $0.02 per share for the quarter. The consensus […]
